Onkos Surgical, a developer of solutions for musculoskeletal oncology and complex orthopaedic procedures, has raised $15 million in Series C funding from its existing investor syndicate, which includes 1315 Capital, Canaan, and 3D Systems.

With the firm's Precision Orthopaedics approach, surgeons are better informed about patient-specific clinical challenges and are able to plan and implement a more precise reconstruction.